IL-17 secreted by γδ T cells may directly act on CD4+ T cells, si

IL-17 secreted by γδ T cells may directly act on CD4+ T cells, since in vitro stimulation with Fulvestrant molecular weight IL-17A and IL-23 upregulates IL-17A/F mRNA expression in CD4+ T cells 37, or indirectly, by conditioning resident APCs. Moreover, this early IL-17 production may also act directly on APCs, such as macrophages and subsets of DCs, which are known to express IL-17R more abundantly than T cells, and provoke APC

production of IL-23, IL-1, IL-6 and TGF-β1 37, 55, which are crucial factors for pathogenic Th17-cell development. Consistently, IL-17 secretion is significantly more elevated in mucosal tissues, where we detected an elevated level of IL-1β and IL-6 mRNA expression. Importantly, our results show that CD4+CD25+Foxp3+ TREG cells directly suppress the proliferation and differentiation of γδ T cells in vitro and in vivo. Moreover, we show that in the context of mucosal inflammation, TREG cells restrain the proliferation of resident γδ T cells more strongly than donor CD4+CD25− TEFF cells, although a similar potency in TREG cell-mediated suppression of both populations is observed in vitro. This finding is consistent with a recent study showing that TREG cells inhibit γδ T-cell proliferation in vitro 32, 40. It is possible that the more potent TREG-cell suppression

of IL-17 secretion compared with IFN-γ secretion seen in the mucosal tissue occurs as a result of a more profound inhibition of γδ T-cell expansion in situ. Whether this happens due to a greater susceptibility of γδ T cells to direct TREG cell-mediated this website suppression or indirect inhibition mediated by TREG cell-conditioned APCs requires further investigation. Interestingly, in contrast to γδ T cells, a significant fraction (around 30%) of CD4+ TEFF cells found in mucosa-associated tissues co-expressed Anidulafungin (LY303366) IFN-γ and IL-17, an observation reminiscent of recent human studies showing the existence of IFN-γ/IL-17 dual producing CD4+ T cells in colonic biopsies of CD patients 25. Furthermore, our results

demonstrate that both CD4+ and γδ T cells from mucosal tissues of recipient mice are more activated as they display a higher proliferation rate and secrete more pro-inflammatory cytokines compared to cells from LNs. Although TREG cells are not able to completely inhibit priming of the pro-inflammatory TEFF cells in the mucosa-draining lymphoid tissues (mesLN), the dramatic reduction in absolute numbers of LP-infiltrating lymphocytes suggests that TREG cells regulate the influx and/or expansion of activated αβ and γδ TEFF-cell subsets in the site of tissue inflammation. These results are consistent with a recent study by Park et al., which identifies IL-10 as a potential mediator in Foxp3+ TREG cell-mediated suppression of γδ T cells 32.

In particular, the consensus scoring procedure improves predictio

In particular, the consensus scoring procedure improves prediction of binding energies, which is the greatest problem in virtual screening. EPZ-6438 price Although the obtained binding energy predictions are still inaccurate and further development

is required before they can be used for this purpose in routine lead optimization, the consensus scoring procedure is at present the only alternative for improvement of the in silico screening procedure. Wang & Wang (2001) distinguished three main ranking methods of consensus scoring for virtual screening: rank-by-number (all the candidates are ranked according to the average predicted values given by all the scoring functions), rank-by-rank (all the candidates are ranked by the average ranks predicted by all the involved scoring functions) and rank-by-vote (if a candidate is predicted to be on the top, for example 2%, by a certain scoring function,

then it gets a ‘vote’ from that scoring function; the final score of a candidate compound is the number of votes gathered from all the scoring functions, which may range from 0 to the total number of scoring functions). see more The approach we applied may be treated as a modification of rank-by-number method, as we used a sum of total score by Surflex and a doubled value of fit obtained with the Screen Library module of discovery studio 2.1. Although most of the proposed hits are characterized by lipophilicity <2 (the range for CNS active drugs is from 2 to 4) and do not cross blood–brain barrier easily, it is obvious that they should be treated as prototypes of drugs that require further optimization (especially of their ADMET properties) before reaching the market. The studies performed allowed 15 potential inhibitors to be selected from the database of 1 161 000 compounds, which constitutes the reasonable alternative for experimental HTS procedure. Moreover, novel structural features of JEV NS3 helicase/NTPase have been identified,

including new important residues in the enzyme-binding pocket. The problem of anti-JEV specificity of novel compounds and their selectivity over human ATPases was also addressed. To conclude, the computational project performed may be treated as a guide for experimental very work on viral helicases/NTPases and antiviral drug design. Calculations were performed under a computational grant by the Interdisciplinary Centre for Mathematical and Computational Modelling, Warsaw, Poland, grant number G30-18. “
“T-cell help is essential for CTL-memory formation. Nevertheless, it is unclear whether the continuous presence of CD4+ T-helper (Th) cells is required during dendritic cell (DC)/CD8+ T-cell encounters, or whether a DC will remember the helper signal after the Th cell has departed. This question is relevant for the design of therapeutic cancer vaccines. Therefore, we investigated how human DCs need to interact with CD4+ T cells to mediate efficient repetitive CTL expansion in vitro.

Care must be taken to avoid contamination of fetal DNA with mater

Care must be taken to avoid contamination of fetal DNA with maternal DNA; detection of such contamination can be performed by short tandem repeat (STR) analysis. The same strategy as for prenatal diagnosis of X-CGD can be used for prenatal diagnosis of other CGD subtypes [40], although this may be more complicated if the parents each carry different mutations. In cases where the family-specific mutations are not known, different methods must be applied. Partial

or complete gene deletions can be recognized by MLPA or array CGH analysis of genomic DNA, but more subtle abnormalities require the use of allele-specific markers. The MLPA or CGH probes and the allele-specific markers should be chosen in the surroundings of the gene that is supposed to be mutated. Step-by-step protocols for laboratory diagnostics (short and extensive) are PLX3397 chemical structure given in Tables 3 and 4 and in Fig. 1. D. R. obtained financial support from the Chronic Granulomatous Disorder Society, London, UK, and from the European Commission E-Rare ABT-263 cost program (EURO-CGD grant). The authors declare no conflicting interests. D. R. and M. d. B. wrote the paper together. “
“Citation Pertyńska-Marczewska M, Głowacka E, Grodzicka A, Sobczak M, Cypryk K, Wilczyński JR., Wilczyński J. Profile of peripheral blood neutrophil cytokines in diabetes type 1 pregnant women and its correlation with selected parameters in the newborns. Am J Reprod Immunol 2010; 63: 150–160

Problem  Interleukin (IL)-12, IL-10, tumor necrosis factor-α (TNF-α), IL-6 and IL-8 alter as pregnancy progresses, implying continuous immune regulation associated with the maintenance of pregnancy. We aimed to evaluate the peripheral blood neutrophil-derived production of these cytokines in the course of pregnancy complicated by type 1 diabetes. Method of study  These parameters were measured in samples from healthy non-pregnant (C), diabetic non-pregnant (D), healthy

pregnant (P) and pregnant diabetic (PD) women. Results  Neutrophil-derived secretion of TNF-α and IL-12 increased along with progression of pregnancy Fludarabine mouse in PD and P groups. The concentration of IL-10 from lipopolysaccharide (LPS)-stimulated neutrophils increased during the course of uncomplicated pregnancy but decreased in diabetic pregnancy. Concentration of IL-8 decreased with the advancing gestational age in P and PD groups. LPS-stimulated neutrophil-derived IL-6 concentration increased only in PD patients. Conclusion  Our results show that diabetes creates pro-inflammatory environment thus potentially influencing the outcome of pregnancy. We conclude that neutrophil-derived cytokine production could contribute to the complications seen in pregnant women with type 1 diabetes. “
“Prior murine studies have demonstrated the pivotal role that Blimp-1 has in the exhausted phenotype of T lymphocytes in chronic viral infection. In this issue of the European Journal of Immunology, Seddiki et al. [Eur. J. Immunol. 2013.

Taking

Taking Selleck Fulvestrant monocytes from patients with MWS, the Tschopp group demonstrated that the processing and secretion of IL-1β was markedly elevated in comparison with monocytes from healthy individuals and further demonstrated that this was due to oligomerization of intracellular proteins with NLRP3 for the conversion of pro-caspase-1 to active caspase-1 and hence the cleavage of the IL-1β precursor.

The complex required NLRP3 and ASC and the mutation was a gain of function mutation for the processing and secretion of active IL-1β. Tschopp named the caspase-1-activating complex “the inflammasome” 16. Mice deficient in NLRP3 or ASC often resisted IL-1β-mediated inflammation similar to that observed in mice deficient in caspase-1. In the present issue of this journal, Jürg Tschopp summarizes his views on the importance

of the molecular contribution of mitochondria to the activation of the NLRP3 inflammasome and states that “mapping the connections between mitochondria, metabolism and inflammation is of great interest, as malfunctioning of this network is associated with many chronic inflammatory diseases” 18. One cannot overstate learn more the importance of Jürg Tschopp’s contributions for understanding the molecular mechanisms of IL-1β-mediated inflammation and its impact on human disease. From the above three discoveries, the concept of auto-inflammation emerges as due to gain of function mutations that participate in the activation of caspase-1 and the secretion of active IL-1β. Although one can also consider auto-inflammatory diseases as due to poor control of caspase-1, any non-infectious disease brought under rapid and sustained control Anidulafungin (LY303366) with

neutralization of IL-1β may be due to endogenous molecules that trigger active IL-1β, regardless of caspase-1 processing. For example, patients with identical disease manifestations in FMF, FCAS, MWS and CINCA who are highly responsive to neutralization of IL-1β and have no mutations in pyrin or NLRP3. Second, another chronic inflammatory disease called hyper IgD syndrome (HIDS) is due to a mutation in mevalonic acid synthesis but patients with HIDS are successfully treated with IL-1β blockade (see Table 1). Third, a growing list of systemic and local diseases are treated by blocking IL-1β activity, but there are no mutations in any component through which caspase-1 activation occurs. However, upon in vitro culture of fresh monocytes from these seemingly unrelated diseases, there is increased release of processed IL-1β 16, 19–23. The rate-limiting step in the release of IL-1β appears to be the translation of the mRNA into the IL-1β precursor. In circulating human blood monocytes, caspase-1 is present in an already active state 24; caspase-1 is also constitutively active in highly metastatic human melanoma cells 25.

Several clinicopathological studies have provided evidence that t

Several clinicopathological studies have provided evidence that the prognosis of patients with MB depends on the histological tumor type. For example, the survival period for patients with anaplastic/large cell MB is shorter than that for patients with CMB.[2-7] Patients with MBEN are expected to have a better outcome

than patients with other types.[8, 9] On the other hand, it is still LY294002 unclear whether DNMB-type histology predicts a favorable outcome. Several investigations have indicated that patients with DNMB survive longer than those with CMB;[10-16] however, others have provided evidence to the contrary.[16, 17] A recent breakthrough in understanding the pathomechanisms of MB has been the discovery of the Sonic Hedgehog (Shh) signaling pathway. Shh is considered to regulate growth and patterning during development

of the cerebellum,[18] and plays an essential role in the tumorigenesis of a subset of MB.[19, 20] Moreover, Shh plays an integral role in a wide variety of developmental processes in vertebrates, and in the development of carcinomas in various organs (Fig. 1A,B). The Shh ligand binds to patched (PTCH) receptors, and inhibits Daporinad price activity against Smoothened on the cytoplasmic membrane. In the on-state, Gli1 and Gli2, the Gli activators in mammals, are produced in the cytoplasm and transported into the nucleus, where various target oncogenes against Shh, including Cyclin D, Cyclin E, Myc, Gli1 and PTCH, are transcribed (Fig. 1B). In the off-state, by contrast, a Gli repressor, Gli3, is produced in the cytoplasm and transported into the nucleus,[21] where it inhibits transcription

of the target oncogenes and promotes normal differentiation (Fig. 1A). It is still unclear whether the expression of the Shh signaling pathway influences the differentiation of MB cells, and consequently affects the outcome of patients with MB. The present study attempted to determine whether expression of Gli3 contributes to neuronal differentiation of the Ketotifen tumor cells and to a favorable outcome for patients with MB. We reviewed the medical records of 32 consecutive patients (19 males, 13 females: age at onset, mean ± SD = 9.7 ± 5.8 years) with pathologically confirmed MB who were referred to the Brain Research Institute, University of Niigata, Japan, between 1982 and 2010. All the patients had undergone maximum possible tumor resection, followed by 30.6 to 36.0 Gy of craniospinal irradiation with a 18.0–23.4 Gy posterior fossa boost. Patients (n = 6: five male, one female: age 8.2 ± 7.2 years) who were admitted to our hospital between 1982 and 1991 had received radiotherapy only. On the other hand, a large proportion of the patients included in the present study (n = 23: 12 males, 11 females: age 9.8 ± 4.

FISH confirmed the presence of Aspergillus and Candida within the

FISH confirmed the presence of Aspergillus and Candida within the infectious process, a prerequisite for inferring a causal relationship with the infection. The combination of broad-range PCR with sequence analysis and FISH applied on tissue samples is a powerful approach Temozolomide ic50 to identify the aetiology of invasive fungal infections, including mixed infections. “
“Fluconazole, which is a drug of the azole family, is safely used in systemic treatment of oral and intravenous injection, but it is difficult to use fluconazole as a topical application because

of its large molecular weight and strong hydrophilic property. This study is a multicentre, double-blind, randomised, non-inferiority study to compare the antifungal effect and safety of fluconazole cream 0.5% and 1% with flutrimazole cream 1% in superficial mycosis. A total of 162 subjects selected to participate in this study were equally divided into three groups and assigned to be given fluconazole cream 0.5%, fluconazole

cream 1%, and flutrimazole cream 1% in the ratio of 1 : 1. The primary index of drug efficacy was determined by complete mycological cure in which no fungus was detected on KOH smear test 4 weeks after application of fluconazole. The secondary index of efficacy was defined as complete mycological cure 4 weeks after the application of fluconazole, improvement of clinical symptoms and overall effectiveness assessed by the research staff. According to this study, on comparing the efficacy of cure of superficial selleck inhibitor dermatomycosis after 4 weeks of application, both fluconazole

0.5% and fluconazole 1% cream were found to be equally effective and non-inferior to flutrimazole 1% cream. Given the effectiveness and safety of the drug, both fluconazole 0.5% and 1% cream might be said to be optimal concentration in the treatment of superficial dermatomycosis. “
“Candida species are the fourth most common cause of nosocomial invasive infections. Biofilm formation is recognised as one virulence factor of Candida species. A total of 243 Candida albicans, 81 C. glabrata, 33 C. parapsilosis, 14 C. dubliniensis, 8 C. tropicalis, 8 C. lusitaniae, 5 C. Thymidine kinase krusei and 1 C. pelliculosa isolates causing bloodstream infections were evaluated for biofilm formation. The biofilm formed on silicone elastomer preincubated with human serum was quantified by estimation of the metabolic activity through XTT assay and visualised by light and scanning electron microscopy. Forty per cent of the C. albicans isolates formed biofilm compared to 88.7% of the non-albicans Candida isolates (P < 0.0001). Among non-albicans Candida spp., biofilm formation was most commonly observed in C. tropicalis and C. lusitaniae (100%), followed by C. glabrata (95%), C. dubliniensis (85.7%) and C. parapsilosis (66.7%). A quantitative correlation was observed between the amount of biofilm observed microscopically, and that determined by metabolic activity measurements.

[11] Anaemia is a common problem in Taiwanese CKD patients Publi

[11] Anaemia is a common problem in Taiwanese CKD patients. Published data indicate that 58.8% of patients with stage 4 CKD in Taiwan are anaemic, and the prevalence selleck compound of anaemia increases to 92.5% in patients reaching stage 5 CKD.[10] On 1 March 1995, Taiwan’s government launched the national health insurance (NHI) system, which ensures the right to healthcare for all residents and provides free access and total coverage of medical expenses for renal replacement therapy.

At the same time, the NHI implemented a fully bundled payment system for HD expenses including the actual cost of dialysis, the cost of dialysis-related laboratory tests, and the cost of using calcium-containing phosphate binders, active vitamin D, and ESAs. In order to promote

the use of peritoneal dialysis (PD), the NHI executed a partially bundled system in the PD treatment payment in which the reimbursement for ESAs was not included. Because almost everyone with ESRD in Taiwan is entitled to the NHI, the incentive to select healthier patients is greatly reduced in the case of dialysis. Erythropoiesis-stimulating agents soon became one of the largest drug expenditures in the NHI program of Taiwan. In 1996, the NHI applied more restrictive reimbursement criteria for ESA use targeting to a lower haematocrit in patients with CKD. ESAs are to be initiated when non-dialysis CKD patients have a serum creatinine >6 mg/dL Thiamet G and a haematocrit <28%, and CH5424802 solubility dmso to maintain a haematocrit level not exceeding 30%. The maximal dose of epoetin-α or β was capped at 5000 U per week, as opposed to 9000 units per week in Japan or 400 000 units per month in the United States. The target haematocrit range and dose limitation for ESAs were the same for dialysis-dependent

CKD patients. We analyzed data from the Taiwan Renal Registry Data System (TWRDS) to examine the national trends of anaemia management in prevalent dialysis patients from 1995 to 2012. The proportion of HD patients with haematocrit <28% declined from 49% to 11%. By contrast, the proportion of those with haematocrit ≥32% rose from 16% to 32% (Fig. 1a). In 1995, mean haemoglobin was 8.9 g/dL (haematocrit 26.8%) in HD patients (Fig. 1b). Mean haemoglobin increased to 10.1 g/dL (haematocrit 30.4%) in 2004, compared with 10.4 g/dL in Japan and 11.7 g/dL in the United States, and rose steadily to 10.5 g/dL (haematocrit 31.6%) in 2012, similar to that in the United States and Japan from the DOPPS study.[12-14] The proportion of HD patients prescribed ESA remained stable at around 80%, compared with 89% in the United States and 91% in Japan. The year trend in haematocrit distribution for PD patients was similar to HD patients (Fig. 1c). However, the proportion of PD patients prescribed ESAs rose from 74.0% in 2006 to 86.2% in 2012 (Fig. 1d).

6C) If the inhibition of L-plastin phosphorylation is a main mod

6C). If the inhibition of L-plastin phosphorylation is a main mode of

action of dexamethasone, then it should also interfere with F-actin stabilization upon antigen recognition. To address this point, we analyzed the effects of dexamethasone on the F-actin content in T cells stimulated with superantigen-bearing APCs using MIFC. The F-actin content in untreated or dexamethasone preincubated T cells was similar if T cells were left unstimulated (Fig. 7A and B). In contrast to the unstimulated situation, the F-actin content was higher in stimulated control T cells (MPI=108.26) compared with dexamethasone-treated and -stimulated T cells (MPI=77.56) (Fig. 7A and B). This finding correlate well to the data observed with cells expressing 5A-LPL since dexamethasone inhibits L-plastin phosphorylation (compare Figs. 4 and 6). Given that L-plastin phosphorylation is mandatory for the inhibitory NVP-BEZ235 XL765 supplier effect of dexamethasone on actin polymerization and immune synapse formation, the expression

of a phospho-mimicking mutant of L-plastin should at least in part revert the phenotype triggered by dexamethasone. An exchange of serine to glutamic acid at position 5 (5E-LPL) was shown to mimic phosphorylated L-plastin 10. We compared T cells expressing EGFP or 5E-LPL regarding its sensitivity toward dexamethasone. In primary human T cells, the expression level of 5E-LPL was relatively low. We therefore used (by gating) only EGFP-positive T cells of the EGFP or 5E-LPL transfections with the same expression level for that comparison (Fig. 7C). Interestingly, while the increase in F-actin following Resminostat T cells stimulation with SEB-loaded APCs was inhibited by dexamethasone in EGFP-expressing T cells, 5E-LPL-expressing T cells showed no inhibition in the F-actin content

in stimulated T cells (Fig. 7D). Moreover, the immune synapse formation was not affected in 5E-LPL-expressing T cells that were pretreated with dexamethasone, whereas EGFP-expressing T cells showed a significantly reduced formation of the immune synapse (Fig. 7E, left graph). Interestingly, 5E-LPL expression could only rescue the disturbed LFA-1 accumulation (Fig. 7E, middle graph), but not the defective CD3 enrichment (Fig. 7E, right graph). Together, these experiments show that inhibition of L-plastin phosphorylation is an important step mediating the disturbed LFA-1 enrichment in dexamethasone-treated T cells. Deliberate and well-regulated immunosuppression is beneficial in treating autoimmune diseases or preventing transplant rejection. One class of frequently used immunosuppressive drugs are glucocorticoids. Here, we introduce a so far unknown mechanism by which the glucocorticoid dexamethasone induces immunosuppression, namely the inhibition of L-plastin phosphorylation, which eventually leads to impaired immune synapse maturation.

Neither of the DNA methyltransferase inhibitors induced fully fun

Neither of the DNA methyltransferase inhibitors induced fully functional human Treg cells. 5-aza-2′-deoxycitidine-treated cells resembled Treg cells, but they did not suppress proliferation of responder cells, which is an essential capability to be used for Treg cell transfer

therapy. Using a recently 5-Fluoracil ic50 developed targeted demethylation technology might be a more promising approach for the generation of functional Treg cells. “
“Secondary hypogammaglobulinemia is one of the factors responsible for the increased susceptibility to infection in patients with chronic lymphocytic leukemia (CLL). This study assessed the therapeutic results, concomitant medication and tolerance of administering 5% intravenous immunoglobulin,

secondary immunodeficiency and recurrent serious bacterial infections. A single center, post-marketing, observational clinical study was performed on 10 patients with a variety of hematological malignancies (CLL, follicular non-Hodgkin lymphoma, IgM-secreting immunocytoma, IgA plasmacytoma and myelodysplastic syndrome/non-Hodgkin lymphoma) who had been infused with IVIG from June 1994 to May 2009. The clinical benefit of IVIG was assessed by comparing the incidence of bacterial infections before and after starting this therapy. Plasma immunoglobulin concentrations and relevant hematological variables were recorded. For safety assessment, adverse events were monitored. The standard IVIG dosage Opaganib ic50 was approximately 0.35 g/kg body weight every 3–4 weeks. Most patients had normal IgG trough values of >600 mg/dL during the IVIG treatment period. The rate of bacterial infections was reduced from 2.4 per patient in the 3 months before IVIG to 0.7 (0–1.5) per patient per year during IVIG treatment. All patients received concomitant medication, mainly

anticancer and anti-anemia therapy (100%). No serious adverse events related to IVIG were observed. The frequency of at least one minor adverse reaction was 1.44% (8/556 infusions). In conclusion, the investigated IVIG preparation was well tolerated and clinically beneficial in reducing the long term rate of serious bacterial DCLK1 infections in patients receiving concomitant treatment for malignant diseases. “
“Mast cell tryptase (MCT) is a key diagnostic test for mastocytosis and anaphylaxis. High serum tryptase levels are also one of the risk factors for adverse reaction in venom immunotherapy, yet occasional patients are seen with raised levels in the absence of either diagnosis. False positive results can be due to assay interference by heterophilic antibodies such as rheumatoid factor (RF) and human anti-mouse antibodies (HAMA). We therefore investigated heterophilic antibody interference by rheumatoid factor activity and HAMA as a cause of raised MCT results in the Phadia tryptase assay.

The current studies are limited by the fact that the measure of p

The current studies are limited by the fact that the measure of performance, infant looking time, has had only modest success as a measure of individual differences (e.g., Frick & Richards, 2001). It has been used primarily as a group measure that yields a categorical outcome in which performance is either above chance or not different from chance. Our studies therefore suggest that a gender difference in mental rotation ability exists, but may not be especially sensitive to revealing the magnitude of this difference. However, the recent work of Krogh, Moore, and Johnson (2013) suggests that progress may be achieved by examining

individual differences in posthabituation Sirolimus concentration looking times as a measure of mental rotation performance and correlating them with other measures. Krogh et al. eye-tracked 5-month-olds while they performed a mental rotation task and observed selleck products that males allotted more visual attention to the top of the stimulus and that higher levels of this top-bias were associated with successful performance; by contrast, female visual attention was distributed more evenly throughout the stimulus and with no relation to performance. Additionally, Krogh et al. reported

a positive relation in females, but not in males, between mental rotation performance and prior tactile manipulation with the three-dimensional object to be presented in the looking time task. Taken together, the findings of Krogh et al. suggest that there may be different determinants of performance for male and female infants in mental rotation tasks. An additional possibility worth exploring in future work is whether Montelukast Sodium males and females might be only quantitatively different, rather than qualitatively different, in their mental rotation abilities. Such a possibility might be manifested if females were found capable of performing at an above-chance level in the mental rotation task, but just needed more time to complete it. It is additionally worth

noting that the procedure used in our second study suggests that the gender difference exists between 3 and 10 months, but is not well-suited to determining whether this difference increases during that time window as has been reported for the time period between childhood and adulthood (Geiser, Lehmann, & Eid, 2008). Additional studies could examine whether a sex difference in infant mental rotation changes in magnitude over time. This research was supported by NIH Grant HD-46526. The authors thank Scott P. Johnson and an anonymous reviewer for helpful comments on the initial submission, and Paige Valeski and Laurie A. Yarzab for their assistance. “
“An abundance of experience with own-race faces and limited to no experience with other-race faces has been associated with better recognition memory for own-race faces in infants, children, and adults.